Ketamine Queen Sentenced in Perry Case
A woman known as the “Ketamine Queen,” identified as Jasveen Sangha, has been sentenced to 15 years in federal prison for her role in supplying the ketamine that led to the death of actor Matthew Perry. The case has drawn widespread attention due to Perry’s fame and the circumstances surrounding his 2023 overdose.
Sangha was one of five individuals charged in connection with Perry’s death, but she stood out because she admitted direct responsibility for distributing the drugs that ultimately caused his fatal overdose. Prosecutors described her as operating a drug distribution network from her North Hollywood residence, where she supplied controlled substances—including ketamine—to clients, some of whom were high-profile individuals.
According to court findings, Sangha sold dozens of ketamine vials to an intermediary, who then passed the drugs along to Perry through his personal assistant. Perry, who had a long history of substance abuse, had been undergoing medically supervised ketamine therapy for mental health treatment. However, when he sought higher doses than doctors would prescribe, he turned to illegal suppliers—ultimately leading him to Sangha’s network.
Authorities stated that Perry received multiple doses of ketamine shortly before his death, including injections administered by his assistant. The overdose occurred in October 2023 and was later ruled to involve the acute effects of ketamine, with contributing factors such as drowning.
Sangha pleaded guilty to several serious charges, including distribution of ketamine resulting in death, maintaining a drug-involved premises, and multiple counts of illegal drug distribution. Her plea agreement acknowledged that she knowingly supplied drugs intended for Perry, making her legally accountable for the fatal outcome.
During sentencing, prosecutors emphasized Sangha’s profit-driven behavior, arguing that she continued selling drugs even after becoming aware of the risks and harm associated with her actions. They also pointed to evidence that she had been linked to another fatal overdose in 2019, suggesting a pattern of dangerous conduct.
In court, Sangha expressed remorse, apologizing for the pain caused to Perry’s family and acknowledging the consequences of her actions. Her defense team argued for leniency, citing her lack of prior criminal convictions and efforts toward rehabilitation, including sobriety and personal reform. However, the judge ultimately sided with prosecutors, imposing a 15-year sentence, which was significantly below the maximum possible penalty but still substantial given the severity of the case.
Emotional victim impact statements from Perry’s family played a key role during the proceedings. Family members described their grief as lasting and irreversible, urging the court to impose a strong sentence to reflect the seriousness of the offense and the loss suffered.
The case also highlighted the broader network involved in supplying drugs to Perry. Other defendants—including two doctors, an intermediary, and Perry’s assistant—have pleaded guilty or been sentenced on related charges. Some received lighter penalties, including home confinement or shorter prison terms, leading to debate over disparities in sentencing among those involved.
Ultimately, the sentencing of Sangha represents one of the most significant legal outcomes in the case. It underscores the legal risks faced by individuals involved in drug distribution, particularly when their actions directly contribute to a fatal overdose. The case also reflects ongoing concerns about the intersection of addiction, illegal drug markets, and accountability within the criminal justice system.
⚖️ Key Legal Outcomes
- Jasveen Sangha sentenced to 15 years in federal prison
- Guilty plea included distribution of ketamine resulting in death
- Court recognized direct responsibility for supplying fatal drugs
- Multiple co-defendants also convicted, with varying sentences
- Case establishes strong precedent for liability in overdose-related drug distribution
📊 Why It Matters
- Highlights legal accountability for drug suppliers in overdose deaths
- Shows how addiction can intersect with illegal supply networks
- Raises questions about sentencing disparities among defendants
- Emphasizes risks of unregulated drug use even during medical treatment
- Reinforces broader efforts to combat illicit drug distribution systems
